Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
Herrera-Van Oostdam AS, Castañeda-Delgado JE, Oropeza-Valdez JJ, Borrego JC, Monárrez-Espino J, Zheng J, Mandal R, Zhang L, Soto-Guzmán E, Fernández-Ruiz JC, Ochoa-González F, Trejo Medinilla FM, López JA, Wishart DS, Enciso-Moreno JA, López-Hernández Y.
Herrera-Van Oostdam AS, et al. Among authors: fernandez ruiz jc.
PLoS One. 2021 Aug 30;16(8):e0256784. doi: 10.1371/journal.pone.0256784. eCollection 2021.
PLoS One. 2021.
PMID: 34460840
Free PMC article.